Wellcome Global Monitor 2026: Trust in Science Under Pressure
Dementia ResearcherTrust in science has fallen since the pandemic, finds the Wellcome Global Monitor 2026, but the UK remains one of the highest-trust countries.
Research News
Do Amyloid Drugs Slow Tau? One Patient’s Brain Offers Clues
A rare autopsy of an aducanumab-treated patient found brain regions cleared of amyloid had less tau and slower atrophy than neighbouring regions that didn’t.
Poster Talks from Alzheimer Europe 2026 | Watch the Playlist
19 poster talks from Alzheimer Europe 2026 in Dublin, short videos on lived experience, carers, social care, creative therapies and more
Young-Onset Dementia: England’s Hidden Population
95% of councils can’t record young-onset dementia separately, finds a new Care England and Dementia Forward report, leaving care largely unplanned.
A collaborative approach to palliative care in dementia
Recording of EMPOWER Dementia Network+’s session on palliative and end-of-life care in dementia, with a geriatrician, palliative consultant and Admiral Nurse.
UK experts set out who should get an Alzheimer’s blood test
New ABN and RCPsych guidance makes p-tau217 the Alzheimer’s blood test of choice, but only within specialist assessment when Alzheimer’s is already suspected.
11.4 million new dementia cases a year, and they are not evenly spread
A 22-cohort meta-analysis puts global dementia incidence at 11.4 million new cases in 2023, rising to 24.7 million by 2050, higher in women and in LMICs.
AD-SMART Alzheimer’s Platform Trial Launches in the UK
AD-SMART, a new UK platform trial, will test several Alzheimer’s drugs at once, starting with two repurposed medicines used for diabetes and ADHD.
Experts set out what AI brain scan tools need to reach memory clinics
Sixteen experts agreed eight statements on what AI neuroimaging tools need before memory clinics can use them, from diverse training data to clinician trust.
PhD Salary in Europe: What Doctoral Candidates Are Paid in 29 Countries
What is a PhD salary in Europe? Eurodoc compares 29 countries and finds being employed or on a stipend matters more than where you study.
STEM PhDs: Why Background Still Shapes the Path to PhD
A major new report finds students from low-socioeconomic backgrounds are far less likely to reach a STEM PhD, even with a first from a top university.
The Economic Case for Prioritising Alzheimer’s Disease Policy in Europe
A Biogen-funded CRA analysis estimates that prioritising Alzheimer’s policy could save Europe’s five biggest economies €182 billion by 2036.